Find your next paid study

Substance UseSubstance-Related DisordersAdolescent Substance Use+5 more

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06668571

Observational

Clinician Practice Companion to Address Youth Substance Use

Substance use, including the use of opioids, cannabis, and other drugs, is common among adolescents and young adults, and overdose has become a leading cause o…

Massachusetts General HospitalNCT07725289

Actual pay is set by the research site.

Observational

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

This is a multicenter randomized controlled trial that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessme…

OncologyMyeloid Leukemia, AcuteCancer

University of RochesterNCT06697600

Actual pay is set by the research site.

A Phase 1a, Open-label, Multicenter, Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB548 in Participants With Advanced Solid Malignancies With a KRAS G12D Mutation

The goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the s…

Solid Tumor Malignancies

Kumquat Biosciences Inc.NCT07207707

~$150 – $4,200

Actual pay is set by the research site.

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease

Inflammation occurs in many brain diseases including Alzheimer's disease. In Alzheimer's disease, an abnormal protein called amyloid starts accumulating decade…

Alzheimer DiseaseHealthy

The Methodist Hospital Research InstituteNCT05582200

Actual pay is set by the research site.

Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia

An Open Label Evaluation Phase 1 Trial of the Safety and Pharmacokinetics of MRX-2843 in Adolescents and Adults With Relapsed/Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Mixed Phenotype Acute Leukemia

This is a Phase I, open-label, non-randomized, dose escalation study in adolescents and adults with relapsed/refractory acute myeloid leukemia, acute lymphobla…

~$150 – $4,200

Actual pay is set by the research site.

Meryx, Inc.NCT04872478

Phase I Dose Escalation Study of FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Background: Rhabdomyosarcoma (RMS) is a cancer of soft tissues. It is the most common soft tissue sarcoma seen in children. RMS cancer cells have a protein ca…

Rhabdomyosarcoma

National Cancer Institute (NCI)NCT06865664

~$150 – $2,700

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan Maintenance Treatment With or Without Bevacizumab Versus Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacitu…

Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer

Merck Sharp & Dohme LLCNCT06824467

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

Trial of Topical Fluorometholone as Adjunctive Therapy for Bacterial Corneal Ulcers

The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with …

Keratitis BacterialCorneal Ulcer (Diagnosis)

Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisSarcoidosis+3 more

~$75 – $3,000

Actual pay is set by the research site.

Vishal JhanjiNCT07308938

A Study of the Natural Progression of Interstitial Lung Disease

Data and specimens will be collected longitudinally from patients seen in the UVA Interstitial Lung Disease (ILD) clinic in order to describe the phenotypic ex…

University of VirginiaNCT04896138

Actual pay is set by the research site.

Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more

A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C

This is a phase 1/2, multicenter, open-label umbrella platform study that will evaluate the safety and tolerability of investigational agents with pembrolizuma…

Merck Sharp & Dohme LLCNCT06469944

~$150 – $4,200

Actual pay is set by the research site.

Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults: Exploratory Observational Analysis of Novel Robotic Control Strategies

People with cerebral palsy (CP), muscular dystrophy (MD), spina bifida, or spinal cord injury often have muscle weakness, and problems moving their arms and le…

Muscle WeaknessProblems Moving Their Arms and Legs